MatsukiyoCocokara & Co.
MatsukiyoCocokara & Co. (MSMKF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
msmkf · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MatsukiyoCocokara & Co. (MSMKF) measures how much investors pay for each dollar of the company's trailing earnings. MSMKF's current PE ratio of 16.94x is calculated by dividing its stock price of $16.57 by its TTM earnings per share of $140.18. −10.0% discount vs 5Y avg 18.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2007 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%25.9x
MedianQ3 · 75%403.1x
Max
At 16.94x, MSMKF's current P/E is lower than in 5% of its annual fiscal year readings over the past 20 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MatsukiyoCocokara & Co.You MSMKF | $6.6B | 16.94x | -8.6% | $140.18 |
 COSMOS Pharmaceutical Corporation CSMYF | $3.3B | 16.92x | -8.7% | $390.86 |
 Kyowa Kirin Co., Ltd. KYKOF | $6.7B | 19.39x | +4.6% | $128.18 |
 Raia Drogasil S.A. RADLY | $6.2B | 32.99x | +78.0% | $0.77 |
 Sinopharm Group Co. Ltd. SHTDF | $7.2B | 8.14x | -56.1% | $2.23 |
 Sinopharm Group Co. Ltd. SHTDY | $6.8B | 7.77x | -58.1% | $11.15 |
 Sonic Healthcare Limited SKHCF | $7.2B | 26.00x | +40.3% | $1.07 |
Industry Average 6 peers with valid PE | — | 18.54x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 20.48x | $140.82 | +29.7% | |
2025-03-31 FY2025 | 15.79x | $133.81 | -24.1% | |
2024-03-31 FY2024 | 20.79x | $125.31 | +21.1% | |
2023-03-31 FY2023 | 17.17x | $96.02 | -13.8% | |
2022-03-31 FY2022 | 19.93x | $82.41 | -39.2% | |
2021-03-31 FY2021 | 32.76x | $51.79 | +40.6% | |
2020-03-31 FY2020 | 23.30x | $62.75 | -7.7% | |
2019-03-31 FY2019 | 25.23x | $60.02 | -4.8% | |
2018-03-31 FY2018 | 26.49x | $54.55 | +39.4% | |
2017-03-31 FY2017 | 19.00x | $48.23 | -16.3% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MatsukiyoCocokara & Co. (MSMKF) measures how much investors pay for each dollar of the company's trailing earnings. MSMKF's current PE ratio of 16.94x is calculated by dividing its stock price of $16.57 by its TTM earnings per share of $140.18.
Frequently asked questions
MSMKF pe ratio · 6 questionsMSMKF's current PE ratio is 16.94x as of 2026-06-09, based on a stock price of $16.57 and TTM EPS of $140.18. Data sourced from Financial Modeling Prep via MSMKF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MatsukiyoCocokara & Co. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09